Phase 2, Double-Blind, Placebo-controlled Trial of a C-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine（2024）
Key words
JNK inhibitor,CC-90001,FVC
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined